NASDAQ:ALLR

Allarity Therapeutics Stock Predictions

etoro logo Buy ALLR
*Your capital is at risk
$1.58
-0.110 (-6.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ALLR Prediction Chart

ALLR Predictions History

Latest community submissions for ALLR.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 25, 2025 Bullish $1.13 V 1
Apr 24, 2025 $0.96 -4.76% $1.07 X 89.90% 0
Apr 24, 2025 $0.98 -2.97% $1.07 X 91.59% 0
Apr 24, 2025 Bullish $1.07 V 1
Apr 8, 2025 $0.85 +6.28% $0.751 X 87.40% 0
Apr 8, 2025 $0.83 +3.92% $0.751 X 89.89% 0
Apr 8, 2025 $0.796 +0.00% $0.751 V 94.05% 1
Mar 24, 2025 $0.94 -5.53% $1.00 X 93.53% 0
Mar 24, 2025 $0.96 -3.45% $1.00 X 95.58% 0
Mar 24, 2025 Bullish $1.00 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALLR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALLARITY THERAPEUTICS, INC.
Allarity Therapeutics
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microt...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE